SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

  • This share is currently suspended. It was suspended at a price of 0.125
  • There is currently no data for CRV

Half-yearly Report

1 Sep 2010 11:22

Analyst Investment Management Plc Registration Number 3687441 Interim Unaudited Financial Statements for the 6 Months Ended 31st May 2010 Analyst Investment Management Plc Contents PageDirectors' Statement 3Profit and Loss Account 4Balance Sheet 5 Page 2

Directors' Statement on the Unaudited Interim Results for the Six Months Ended

31st May 2010

The Company made a loss of £33,884 which compares to a profit of £11,697 in the same period last year. Fee income fell to £20,496 (2009: £77,358) which reflects the termination of the investment management agreement with Capita for the CF Analyst UK Fund, consisting of approximately £4 million funds under management. No performance-related fees were earned during the interim 6 month period.

There has been a small decrease in costs, from £48,567 to £40,372 as a result of relocating our offices to Reading. The opportunity to cut costs further is limited and the future success of the business is reliant on increasing funds under management.

The company had assets under management of approximately £8.75m on 31 May 2010.

The recently appointed two new investment managers have brought in additional funds under management of £8.4 million which are expected to increase by a similar amount by the end of the year if pending negotiations with several investors are successful.

We failed to agree terms of arrangements with Mr Sandeep Jaitly who planned to launch the Gold Fund as mentioned in the Chairman's Statement for the year ended 30 November 2009. Mr Jaitly is no longer with the company.

We recently had a formal visit from the FSA who have completed their review and subsequently requested further information. No material exceptions were highlighted, however. We have reported our dispute with Capita to the FSA, and a decision as to any further action will be taken soon.

The previous fund manager who left the company on 30 November 2009 has made a claim for unfair dismissal which has been referred to the Employment Tribunal. Specialist employment lawyers have been appointed to represent the company and are reviewing all the documentation whilst waiting for a hearing date.

We are pleased at the progress so far made by our two new investment managers, and continue to identify further opportunities to enhance the business

This Statement has been prepared by and is the sole responsibility of the directors of Analyst Investment Management plc.

CHAIRMAN FINANCE DIRECTORBharat Amin Surbjit Chadda31 August 2010 Page 3 Analyst Investment Management Plc Profit And Loss Account For The Six Months Ended 31 May 2010 Unaudited Unaudited Audited Six Months Six Months 12 months ended 31 ended 31 ended 30 May 2010 May 2009 Nov 2009 £ £ £Turnover 20,496 77,358 95,607Cost of sales (14,008) (17,895) (36,249) ______ ______ ______Gross profit 6,488 59,463 59,358Administrative expenses (40,372) (48,567) (98,550) ______ ______ ______Operating (loss)/profit (33,884) 10,896 (39,192)Other interest receivable and similar income - 801 6,801 ______ ______ ______(Loss)/profit on ordinary activities before taxation (33,884) 11,697 (32,391)Taxation - - - ______ ______ ______(Loss)/profit on ordinary activities after taxation (33,884) 11,697 (32,391) ______ ______ ______(Loss)/earnings per share (pence) (0.459) 0.159 (0.439) ______ ______ ______

The turnover for the 6 months to 31 May 2009 includes the performance fee of £58,724 earned in the year to 30 November 2008.

The earnings per share are based on the loss after taxation of £33,884 (2009: profit £11,697), and the weighted average number of ordinary 2.5 pence shares in issue during the period of 7,377,777 shares, (2009: 7,377,777 shares). Ordinary 2.5 pence shares in issue at 31st May 2010 were 7,377,777.

Page 4 Analyst Investment Management Plc Balance Sheet As at 31 May 2010 Unaudited Unaudited Audited as at 31 as at 31 as at 30 May 2010 May 2009 Nov 2009 £ £ £Current assetsDebtors 7,277 11,532 12,464Cash at bank and in hand 433,603 503,820 462,300 ______ ______ ______ 440,880 515,352 474,764Creditors: amounts fallingdue within one year (3,500) - (3,500) ______ ______ ______Net Current Assets 437,380 515,352 471,264 ______ ______ ______Net Assets 437,380 515,352 471,264 ______ ______ ______Capital and reservesCalled up share capital 184,444 184,444 184,444Share premium account 1,100,642 1,100,642 1,100,642Profit and loss account (847,706) (769,734) (813,822) ______ ______ ______Equity Shareholders' Funds 437,380 515,352 471,264 ______ ______ ______ Page 5

vendor
Date   Source Headline
24th Jul 20257:00 amRNSCancellation - Craven House Capital PLC
23rd Jun 202510:30 amRNSWithdrawl of 'Stmt re Share Price Movement' RNS
23rd Jun 202510:05 amRNSStatement re Share Price Movement
23rd Jun 20257:30 amRNSSuspension - Craven House Capital Plc
23rd Jun 20257:00 amRNSResignation of Nominated Adviser
27th Feb 20257:00 amRNSInterim Results
7th Feb 20254:22 pmRNSTR-1: Notification of major holdings
16th Dec 20242:42 pmRNSResult of AGM
15th Nov 20247:00 amRNSAnnual Results For Year Ended 31 May 2024
10th Sep 20247:00 amRNSInvestee company update: RoseMonkey Ltd
27th Aug 20247:00 amRNSTR-1: Notification of major holdings
23rd Aug 20242:19 pmRNSTR-1: notification of major holdings
5th Jun 20247:00 amRNSInvestee Companies' Update: Bio Vitos
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.